Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00514254 · ClinicalTrials.gov registry record
Risk Factors for Endometrial Cancer in Black Women
A clinical trial of Endometrial Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 59
- Enrollment target
- 4
- Study locations
NCT00514254 is a study of Endometrial Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 59 participants, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT00514254, a study of Endometrial Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 59 participants
- Enrollment target
- 4
- Study locations
Study Summary
RATIONALE: Learning about the risk factors for endometrial cancer in black women may help the study of endometrial cancer in the future. PURPOSE: This clinical trial is studying risk factors for endometrial cancer in black women.
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER study of socioeconomic and demographic variables
- PROCEDURE evaluation of cancer risk factors
Study Locations (4)
New York
- SUNY Downstate Medical Center - Brooklyn
- City College of New York - New York
- Memorial Sloan Kettering Cancer Center - New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2007-07 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00514254
The ClinicalTrials.gov registry entry for NCT00514254 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 3 interventions - of which questionnaire administration is the first listed.
NCT00514254 reports 4 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00514254 about?
NCT00514254 is a clinical study titled "Risk Factors for Endometrial Cancer in Black Women". RATIONALE: Learning about the risk factors for endometrial cancer in black women may help the study of endometrial cancer in the future. PURPOSE: This clinical trial is studying risk factors for endometrial cancer in black women.
What is the current status of trial NCT00514254?
This trial is currently active not recruiting. The enrollment target is 59 participants. The study started on 2007-07. Estimated completion is 2026-07.
What conditions does trial NCT00514254 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT00514254?
The interventions under investigation include: questionnaire administration (OTHER), study of socioeconomic and demographic variables (OTHER), evaluation of cancer risk factors (PROCEDURE).
Who is sponsoring clinical trial NCT00514254?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00514254 being conducted?
This trial has 4 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.